Publication | Open Access

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

Lymphoid NeoplasiaMedicineMalignant Blood DisorderImmunologyPathologyImmunotherapyOncologyRadiation Oncology